An underground economy for unapproved slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.
Investigational Drug Gaining Popularity Online
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are encouraged to contact these profiles directly for source information, while also receiving discount codes.
Thriving Commerce on Messaging Platforms
Separately, a flourishing market exists on Telegram, where groups with thousands of participants share comparison images, injection guides and claims of next-day British shipping. Vendors promote the drug there before redirecting buyers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.
Medical Experts Express Worries
However, doctors and chemists have cautions that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could lead to users injecting products of uncertain source.
Several professionals said the popularity for retatrutide could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.
Regulatory Position and Enforcement
Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate medicines, advertising, and customer regulations, risking fines, prosecution or prison.
Service Response and Material Removal
Based on TikTok, the platform has removed violative material and prohibited associated hashtags and search suggestions. The company said it was committed to keeping the service safe and investing in strengthening enforcement strategies.
Digital Trading Operations
Research also found communities with up to nine thousand members marketing the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of users, filled with images of slimming results, positive testimonials and step-by-step guides for preparing or administering at residence.
After moments of joining one group, a seller shared WhatsApp details, where the majority of purchases occur. The seller sent an instruction manual and guaranteed shipping within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None asked about body mass, medical conditions or past usage.
Product Information and Pricing
Within these groups, posts show black plastic packages with postal service labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at residence with purified liquid, or pre-filled pens usually priced at £160 for 20mg. When questioned how much time a pen should last, sellers give contradictory answers varying between a several days to “depends on your body”.
Service Moderation and Security Actions
A representative for Telegram stated it regularly moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are injecting materials they can’t verify. Although the science behind retatrutide is valid, these digital products may not include what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.
Her team has already seen patients harmed by personal administration from unverified sources. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”
Producer Statement
A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose users to possibly serious health risks”.
